| Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics Y Wang, S Zhang, F Li, Y Zhou, Y Zhang, Z Wang, R Zhang, J Zhu, Y Ren, ... Nucleic acids research 48 (D1), D1031-D1041, 2020 | 619 | 2020 |
| Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents Y Zhou, Y Zhang, X Lian, F Li, C Wang, F Zhu, Y Qiu, Y Chen Nucleic Acids Research 50 (D1), D1398-D1407, 2022 | 170 | 2022 |
| Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs YH Li, XX Li, JJ Hong, YX Wang, JB Fu, H Yang, CY Yu, FC Li, J Hu, ... Briefings in Bioinformatics 21 (2), 649-662, 2020 | 135 | 2020 |
| NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data Q Yang, Y Wang, Y Zhang, F Li, W Xia, Y Zhou, Y Qiu, H Li, F Zhu Nucleic Acids Research 48 (W1), W436-W448, 2020 | 133 | 2020 |
| VARIDT 1.0: variability of drug transporter database J Yin, W Sun, F Li, J Hong, X Li, Y Zhou, Y Lu, M Liu, X Zhang, N Chen, ... Nucleic Acids Research 48 (D1), D1042-D1050, 2020 | 128 | 2020 |
| How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from trichostatin a enantiomers based on molecular dynamics Y Zhang, JB Ying, JJ Hong, FC Li, TT Fu, FY Yang, GX Zheng, XJ Yao, ... ACS Chemical Neuroscience 10 (5), 2467-2480, 2019 | 78 | 2019 |
| POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability F Li, Y Zhou, Y Zhang, J Yin, Y Qiu, J Gao, F Zhu Briefings in Bioinformatics 23 (2), 2022 | 61 | 2022 |
| INTEDE: interactome of drug-metabolizing enzymes J Yin, F Li, Y Zhou, M Mou, Y Lu, K Chen, J Xue, Y Luo, J Fu, X He, J Gao, ... Nucleic Acids Research 49 (D1), D1233-D1243, 2021 | 55 | 2021 |
| SSizer: determining the sample sufficiency for comparative biological study F Li, Y Zhou, X Zhang, J Tang, Q Yang, Y Zhang, Y Luo, J Hu, W Xue, ... Journal of molecular biology 432 (11), 3411-3421, 2020 | 53 | 2020 |
| VARIDT 2.0: structural variability of drug transporter T Fu, F Li, Y Zhang, J Yin, W Qiu, X Li, X Liu, W Xin, C Wang, L Yu, J Gao, ... Nucleic Acids Research 50 (D1), D1417-D1431, 2022 | 49 | 2022 |
| RNA–RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection S Zhang, K Amahong, C Zhang, F Li, J Gao, Y Qiu, F Zhu Briefings in bioinformatics 23 (1), bbab397, 2022 | 38 | 2022 |
| SYNBIP: synthetic binding proteins for research, diagnosis and therapy X Wang, F Li, W Qiu, B Xu, Y Li, X Lian, H Yu, Z Zhang, J Wang, Z Li, ... Nucleic Acids Research 50 (D1), D560-D570, 2022 | 32 | 2022 |
| The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations Y Zhang, G Zheng, T Fu, J Hong, F Li, X Yao, W Xue, F Zhu Physical Chemistry Chemical Physics 22 (9), 5132-5144, 2020 | 28 | 2020 |
| ConSIG: consistent discovery of molecular signature from OMIC data F Li, J Yin, M Lu, Q Yang, Z Zeng, B Zhang, Z Li, Y Qiu, H Dai, Y Chen, ... Briefings in Bioinformatics 23 (4), bbac253, 2022 | 27 | 2022 |
| PFmulDL: a novel strategy enabling multi-class and multi-label protein function annotation by integrating diverse deep learning methods W Xia, L Zheng, J Fang, F Li, Y Zhou, Z Zeng, B Zhang, Z Li, H Li, F Zhu Computers in Biology and Medicine 145, 105465, 2022 | 27 | 2022 |
| Biomarker discovery for immunotherapy of pituitary adenomas: enhanced robustness and prediction ability by modern computational tools Q Yang, Y Wang, S Zhang, J Tang, F Li, J Yin, Y Li, J Fu, B Li, Y Luo, ... International Journal of Molecular Sciences 20 (1), 151, 2019 | 25 | 2019 |
| Identification of the gene signature reflecting schizophrenia’s etiology by constructing artificial intelligence‐based method of enhanced reproducibility QX Yang, YX Wang, FC Li, S Zhang, YC Luo, Y Li, J Tang, B Li, YZ Chen, ... CNS Neuroscience & Therapeutics 25 (9), 1054-1063, 2019 | 24 | 2019 |
| Assessing the effectiveness of direct data merging strategy in long-term and large-scale pharmacometabonomics X Cui, Q Yang, B Li, J Tang, X Zhang, S Li, F Li, J Hu, Y Lou, Y Qiu, W Xue, ... Frontiers in Pharmacology 10, 127, 2019 | 19 | 2019 |
| GIMICA: host genetic and immune factors shaping human microbiota J Tang, X Wu, M Mou, C Wang, L Wang, F Li, M Guo, J Yin, W Xie, ... Nucleic Acids Research 49 (D1), D715-D722, 2021 | 18 | 2021 |
| Databases for the targeted COVID‐19 therapeutics Y Wang, F Li, Y Zhang, Y Zhou, Y Tan, Y Chen, F Zhu British Journal of Pharmacology 177 (21), 4999, 2020 | 15 | 2020 |
JIAYI YINZhejiang University在 zju.edu.cn 的电子邮件经过验证
